[Today's focus]

ICBC (01398.HK) achieved net profit of 365.116 billion yuan in 2023, a year-on-year increase of 0.8%

ICBC (01398.HK) issued an announcement that in 2023, the Bank will adhere to the general tone of steady progress, actively and proactively address multiple internal and external challenges, coordinate development and security, continuously improve the quality and efficiency of financial services, and simultaneously promote its own high-quality development. Net profit for the year was 365.116 billion yuan, an increase of 3.06 billion yuan over the previous year, an increase of 0.8%, an average return on total assets of 0.87%, and a weighted average return on equity of 10.66%. Revenue decreased 4.3% to $806.458 billion. Among them, net interest income was 655.013 billion yuan, a decrease of 5.3%; non-interest income was 151,445 billion yuan, an increase of 0.7%. Operating expenses were 238.698 billion yuan, a decrease of 0.3%, and the cost-revenue ratio was 28.28%. Accrued asset impairment losses of $150.816 billion. Income tax expenses amounted to $56.850 billion, a decrease of 9.2%.

At the end of 2023, various loans amounted to $26,86.482 billion, an increase of $2,876,106 billion over the end of the previous year, an increase of 12.4%. Among them, loans from domestic branches amounted to RMB 243,91,525 billion, an increase of RMB 2,908.561 billion, or 13.5%.

According to the five-level classification, normal loans at the end of 2023 were 25,25,275 billion yuan, an increase of 2812.697 billion yuan over the end of the previous year, accounting for 96.79% of various loans; focus on loans of 482.705 billion yuan, an increase of 31,077 billion yuan, accounting for 1.85%, a decrease of 0.10 percentage points; non-performing loans amounted to 353.502 billion yuan, an increase of 32.332 billion yuan, a decrease of 0.02 percentage points.

The Bank's board of directors proposed a cash dividend for 2023 common shares, based on 356,406,257,089 common shares, with a total dividend of approximately RMB3.064 (tax included) for every 10 shares.

[Important matters]

China Aluminum (02600.HK): Joint investment with Chinalco High-end Manufacturing to establish a joint venture

[Financial results]

Bank of Communications (03328.HK) achieved net profit of 92,728 billion yuan in 2023, a year-on-year increase of 0.68%

Everbright Bank (601818.SH): Net profit of RMB 40.792 billion in 2023 fell 8.96% year on year

Haier Smart Home (06690.HK) announced annual results: net profit to mother reached 16.597 billion yuan, up 12.8% year-on-year, and proposed final interest of 0.804 yuan per share

CGN Power (01816.HK) announced annual results with net profit of about 10.72 billion yuan to achieve safe and stable operation of all nuclear power units in operation

Fosun International (00656.HK)'s 2023 revenue of 19.20 billion yuan increased 8.6% year-on-year

Xinhua Insurance (01336.HK): Net profit due to mother of 8.712 billion yuan in 2023 decreased by 11.3% year-on-year

Longyuan Electric Power (00916.HK): Net profit of 6.355 billion yuan to mother increased 23.9% year-on-year in 2023

Bank of Chongqing (01963.HK) achieved net profit of 5.229 billion yuan in 2023, a year-on-year increase of 2.20%

Shanghai Industrial Holdings (00363.HK) net profit of HK$3.424 billion in 2023 increased 48.0% year-on-year

Fufeng Group (00546.HK) net profit of 3.1 billion yuan in 2023 decreased by 18.6% year-on-year

Orient Securities (03958.HK) net profit of 2,754 billion yuan in 2023 fell 8.53% year on year

China Southern Airlines (600029.SH): Net loss of 4.209 billion yuan in 2023, year-on-year loss reduction

Yuexiu Capital (000987.SZ): Net profit in 2023 fell 4.33% to 2,404 billion yuan, and plans 10 to 1.7 yuan

CIMC's net profit in 2023 was 1,863 billion yuan, and offshore revenue surged 81.12% year-on-year to RMB 10.452 billion

The annual net profit of the Sichuan-Cheng-Chongqing Expressway (00107.HK) increased by 89.95% to 1,191 billion yuan, and the proposed dividend payment of 0.24 yuan per share

The annual net profit of Shougang Resources (00639.HK) was approximately HK$2.301 billion, down about 30% year-on-year

China Civil Aviation Information Network (00696.HK): Net profit of 1,399 billion yuan in 2023 increased by 123.1% year-on-year

Xinhua Wenxuan (00811.HK): Net profit to mother of 1,579 billion yuan increased 13.1% year-on-year in 2023

Evergrande Property (06666.HK) net profit of about 1,564 billion yuan in 2023 increased by about 5.8% year-on-year

Profit attributable to shareholders of Changhong Jiahua (03991.HK) in 2023 was approximately HK$360 million, down about 1.44% year on year

Baiguoyuan Group (02411.HK)'s 2023 profit increased by about 11.9% to 362 million yuan

Huitongda Network (09878.HK) net profit of 448 million yuan in 2023 increased by 41.7% year-on-year

Jiahong Education (01935.HK): Core net profit of 527 million yuan decreased by 10% year-on-year in 2023

Jinxin Reproduction (01951.HK) net profit of about 347 million yuan in 2023 increased by 194.2% year-on-year

Jinke Services (09666.HK) owners should account for losses of approximately $951 million in 2023

[Operational data]

The total consolidated electricity sales volume of China Electric Power (02380.HK) in February was 9.076 million megawatt-hours, up 30.42% year-on-year

Datang New Energy (01798.HK) completed 2.75,000 megawatt-hours of power generation in February, an increase of 9.23% year-on-year

[Pharmaceutical Innovation]

Yuanda Pharmaceutical (00512.HK) introduces innovative global products to treat demodex mite blepharitis and meibomian gland dysfunction caused by demodex

Tomoshibayu Bio-B (02496.HK): Phase III clinical trial of the bispecific antibody M701 malignant ascites completed the first patient enrollment

[Acquisition and sale]

Teda Biotech (08189.HK) plans to sell 82.76% of Shanghai Weidi's shares for 10.593 million yuan

Guofu Innovation (00290.HK) plans to buy cryptocurrency and subscribe to virtual asset funds

[Equity Incentives]

Guofu Innovation (00290.HK) grants 91.5 million share options

Pharmaceutical Biotech (02269.HK): Grants a total of 19.3722 million restricted shares under the Restricted Share Award Program

SMORE International (06969.HK) grants a total of 390,000 bonus shares

[Repurchase Cancellation]

Tencent Holdings (00700.HK) spent HK$1.02 billion to buy back 3.29 million shares on March 27

AIA (01299.HK) spent HK$315 million to buy back 5.95 million shares on March 27

HSBC Holdings (00005.HK) spent HK$305 million to buy back 4.936,800 shares on March 26

Changshi Group (01113.HK) spent HK$134 million to buy back 4.167 million shares on March 27

China Petroleum & Chemical Co., Ltd. (00386.HK) spent HK$87.924 million to buy back 20 million shares on March 27

Standard Chartered Group (02888.HK) spent £8.0949 million to buy back 1.175,500 shares on March 26

Kuaishou-W (01024.HK) spent HK$39.966 million to buy back 830,000 shares on March 27

Shell-W (02423.HK) spent 6 million US dollars to buy back 1.28 million shares on March 26

On March 27, Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 424,700 A shares

Conch Venture (00586.HK) spent HK$16.9824 million to repurchase 3.127 million shares on March 27

Swire Group A (00019.HK) spent HK$9.03 million to repurchase 140,000 shares on March 27

Xiansheng Pharmaceutical (02096.HK) spent HK$9.885 million to buy back 1.836 million shares on March 27

Shunyu Optical Technology (02382.HK) spent HK$19.2415 million to buy back 490,000 shares on March 27

MGM China (02282.HK) spent HK$7.77,700 to buy back 584,800 shares on March 27

Sansheng Pharmaceutical (01530.HK) spent HK$5.744 million to buy back 1 million shares on March 27

Yum China (09987.HK) spent HK$4.69 million to buy back 15,500 shares on March 26

VESYNC (02148.HK) spent HK$3.541 million to repurchase 702,000 shares on March 27

BairongYun-W (06608.HK) spent HK$2,942,000 to repurchase 250,000 shares on March 27